Duchenne gait, characterized by an ipsilateral trunk lean towards the affected stance limb, compensates for weak hip abductor muscles, notably the gluteus medius (GM). This study aims to investigate how electromyographic (EMG) cluster analysis of GM contributes to a better understanding of Duchenne gait in patients with cerebral palsy (CP). We analyzed retrospective gait data from 845 patients with CP and 65 typically developed individuals. EMG activity of GM in envelope format were collected and examined with gait kinematics and kinetics parameters in frontal plane and hip abductor strength, and hip abduction passive range of motion.

Six key EMG envelope features during ten gait phases were extracted and normalized. A hybrid K-means-PSO clustering algorithm was employed, followed by hierarchical clustering. The identified clusters were characterized by having a low (cluster_1), medium (cluster_2), and high (cluster_3) activity of GM during loading response. The patients in cluster_1 also exhibited pathological gait characteristics, including increased trunk lateral lean and weak hip abductor, which are associated with Duchenne gait. The patients in this cluster were subclustered according to their response to the intervention: SUB_1 with a significant improvement in trunk obliquity, pelvic obliquity, and hip abduction after intervention, and SUB_2 without such improvement. Comparing pre-treatment EMG and clinical exam of the sub_clusters, SUB_1 had significantly higher activity of GM during 50-87% of the gait cycle with a greater passive range of hip abduction compared to SUB_2. This study established a relationship between EMG of GM and frontal plane gait abnormalities in patients with CP, highlighting potential improvement in Duchenne gait with prolonged GM activity during swing after the intervention.

The authors have declared no competing interest.

This research was funded by the German Research Foundation (DFG) (no: WO 1624/ 8-1)

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Ethics Committee of the Medical Faculty of Heidelberg University (Heidelberg, Germany; no: S-243/2022)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The data supporting the conclusions of this article is made available along with the publication.